特征
Patients injected with 10 渭g exenatide twice daily were from 鈥榯he comparison of glycemic control and 尾-cell function among newly diagnosed patients with type 2 diabetes treated with exenatide, insulin or pioglitazone: a multicenter randomized parallel-group (CONFIDENCE) study